Citius Pharmaceuticals is trading at $0.53 (6.5% down) in after-hours trading as investors lock in profits following a significant rally during the regular session.
- The stock closed the July 29 regular session up 14.3% at $0.57, but is currently retracing those gains in post-market activity.
- With no new company-specific headlines or earnings releases, the move appears driven by typical after-hours dynamics, including lower liquidity and wider bid–ask spreads.
- Traders are likely securing gains following the sharp intraday rebound seen earlier in the day.